Why the study?
Chronic thromboembolic pulmonary hypertension is a rare, underdiagnosed form of pulmonary hypertension with available curative surgery, alongside rapid advances in targeted medical management and balloon pulmonary angioplasty for inoperable patients.
This review summarizes recent advances in the management of CTEPH, including surgical, medical, and percutaneous interventions.
Chronic thromboembolic pulmonary hypertension is rare, underdiagnosed form of pulmonary hypertension. It is caused by intravascular obstruction of pulmonary arteries due to fibrotic transformation of thromboembolic material and microvasculopathy. It is important to diagnose this variant as potentially curative treatment in the form of pulmonary endarterectomy is available. Last two decades have seen rapid advances in targeted medical management and refinement in balloon pulmonary angioplasty technique, which have provided a viable therapeutic option for patients who deemed to be inoperable.
No takes yet. Share an insight, caveat, or question.
Tyagi et al. (2023) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: